Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 38
- Next page
Title | Authors | Year | Journal | Link to Article | Intended Audience Sort descending | Purpose |
---|---|---|---|---|---|---|
The transfusion-associated dyspnea prospective observation and laboratory assessment study: a protocol for investigating and disambiguating cardiopulmonary and high-grade febrile transfusion reactions in adults | McVey M, Saeed S, Siddiqui R, Armali C, Kron A, Branch D, Brinc D, Zhang L, Shehata N, Pavenski K, Gupta A, Lin Y, Lieberman L, Pendergrast J, Callum J, Cserti-Gazdewich C | 2023 | Int J Clin Trials | View The transfusion-associated dyspnea prospective observation and laboratory assessment study: a protocol for investigating and disambiguating cardiopulmonary and high-grade febrile transfusion reactions in adults | Health care providers | Clinical research |
Chapter 5. Concentrates for hemostatic disorders and hereditary angioedema | Poon MC, Goodyear D, Rydz N, Lee A | 2022 | Clinical Guide to Transfusion | View Chapter 5. Concentrates for hemostatic disorders and hereditary angioedema | Health care providers | Benchmarking and standard setting |
Acetylsalicyclic acid for the prevention and treatment of thromboembolic diseases | Webert K, Kelton J | 2016 | Aspirin and related drugs | View Acetylsalicyclic acid for the prevention and treatment of thromboembolic diseases | Health care providers | Clinical research |
Circulatory Death Determination in Uncontrolled Organ Donors: A Panel Viewpoint | Bernat JL, Bleck TP, Blosser SA, Bratton SL, Capron AM, Cornell D, Devita MA, Fulda GJ, Glazier AK, Gries CJ, Mathur M, Nakagawa TA, Shemie SD | 2014 | Ann Emerg Med | View Circulatory Death Determination in Uncontrolled Organ Donors: A Panel Viewpoint | Health care providers | Other |
Hemostatic Disorders | Poon MC, Goodyear MD, Lee A | 2015 | Clinical Guide to Transfusion | View Hemostatic Disorders | Health care providers | Other |
Isolated bone marrow Hodgkin Lymphoma in a human immunodeficiency virus-negative patient: a second case | Cacoub L, Touati S, Yver M, Frayfer J, Abarah W, Andre-Kerneis E, Branch DR, Forceville X, Fouillard L | 2013 | Leuk Lymphoma | View Isolated bone marrow Hodgkin Lymphoma in a human immunodeficiency virus-negative patient: a second case | Health care providers | Clinical research |
New RHD variant alleles | Garcia F, Rodriguez M-A, Goldman M, Azcarate M-N, Rodriguez M-I, Muniz-Diaz E, Puente F, Alshatti H, Haimila K, Molano A, Garaizar A, Ochoa-Garay G | 2015 | Transfusion | View New RHD variant alleles | Health care providers | Clinical research |
Preoperative Autologous Donation | Lesley P, Clarke G | 2013 | Clinical Guide to Transfusion | View Preoperative Autologous Donation | Health care providers | Benchmarking and standard setting |
Quality of red blood cells washed using a second wash sequence on an automated cell processor | Hansen AL, Turner TR, Kurach JDR, Acker JP | 2015 | Transfusion | View Quality of red blood cells washed using a second wash sequence on an automated cell processor | Health care providers | New or improved product or process |
Risk of exposure to blood products during pregnancy: guidance for Zika and other donor deferral policies | Murphy MS, Shehata N, Colas JA, Chassé M, Fergusson DA, O'Brien SF, Goldman M, Tinmouth A, Forster AJ, Wilson K | 2017 | Transfusion | View Risk of exposure to blood products during pregnancy: guidance for Zika and other donor deferral policies | Health care providers | Clinical research |
Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half-life FIX concentrates | Iorio A, Fischer K, Blanchette V, Rangarajan S, Young G, Morfini M | 2017 | Thromb Haemost | View Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half-life FIX concentrates | Health care providers | Clinical research |
Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections | Charlton CL, Babady E, Ginocchio CC, Hatchette TF, Jerris RC, Li Y, Loeffelholz M, McCarter YS, Miller MB, Novak-Weekley S, Schuetz AN, Tang Y-W, Widen R, Drews SJ | 2018 | Clin Microbiol Rev | View Practical Guidance for Clinical Microbiology Laboratories: Viruses Causing Acute Respiratory Tract Infections | Health care providers | Clinical research |
Hemostatic Disorders and Hereditary Angioedema | Poon MC, Goodyear MD, Rydz N, Lee A | 2018 | Clinical Guide to Transfusion | View Hemostatic Disorders and Hereditary Angioedema | Health care providers | Other |
American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease | Liem RI, Lanzkron S, T DC, DeCastro L, Desai AA, Ataga KI, Cohen RT, Haynes J, Osunkwo I, Lebensburger JD, Lash JP, Wun T, Verhovsek M, Ontala E, Blaylark R, Alahdab F, Katabi A, Mustafa RA | 2019 | Blood Adv | View American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease | Health care providers | Benchmarking and standard setting |
Sélection des donneurs, dépistage des maladies transmissibles et réduction des agents pathogènes | Goldman M, Drews S, Devine D | 2019 | Guide de la pratique transfusionnelle | View Sélection des donneurs, dépistage des maladies transmissibles et réduction des agents pathogènes | Health care providers | Benchmarking and standard setting |
Venous limb gangrene and pulseless electrical activity (PEA) cardiac arrest during management of deep-vein thrombosis and progressive limb ischemic necrosis following vascular surgery | Avram AT, Blostein MD, Hirsch AM, Warkentin TE | 2020 | Am J Hematol | View Venous limb gangrene and pulseless electrical activity (PEA) cardiac arrest during management of deep-vein thrombosis and progressive limb ischemic necrosis following vascular surgery | Health care providers | Clinical research |
Concentré de recherche: Traitement périopératoire des patients atteints de thrombocytopénie immunitaire : comparaison de l’eltrombopag et des immunoglobulines intraveineuses | Arnold DM | 2021 | Blood.ca website | Health care providers | Clinical research | |
Immune thrombocytopenia (ITP) in adults: Second-line and subsequent therapies | George J, Arnold D | 2020 | UptoDate | View Immune thrombocytopenia (ITP) in adults: Second-line and subsequent therapies | Health care providers | Benchmarking and standard setting |
Managing drug shortages during a pandemic: tocilizumab and COVID-19 | Verma AA, Pai M, Saha S, Bean S, Fralick M, Gibson JL, Greenberg RA, Kwan JL, Lapointe-Shaw L, Tang T, Morris AM, Razak F | 2021 | CMAJ | View Managing drug shortages during a pandemic: tocilizumab and COVID-19 | Health care providers | Benchmarking and standard setting |
Surveillance report 2020 | O'Brien S | 2021 | Blood.ca website | View Surveillance report 2020 | Health care providers | Benchmarking and standard setting |
Répercussions de la COVID-19 sur le don de sang au Canada | Khandelwal A | 2021 | Blood.ca website | View Répercussions de la COVID-19 sur le don de sang au Canada | Health care providers | Benchmarking and standard setting |
Syndrome respiratoire aigu post-transfusionnel (TRALI) | Gupta A, Yan M | 2021 | Blood.ca website | View Syndrome respiratoire aigu post-transfusionnel (TRALI) | Health care providers | Benchmarking and standard setting |
Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia | Bourguignon A, Arnold DM, Warkentin TE, Smith JW, Pannu T, Shrum JM, Al Maqrashi ZAA, Shroff A, Lessard M-C, Blais N, Kelton JG, Nazy I | 2021 | N Engl J Med | View Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia | Health care providers | Clinical research |
ResearchUnit: Treatment and detection of vaccine-induced thrombotic thrombocytopenia (VITT) | Abe T | 2021 | Blood.ca website | View ResearchUnit: Treatment and detection of vaccine-induced thrombotic thrombocytopenia (VITT) | Health care providers | Clinical research |
Chapitre 19. Plaquettes à teneur réduite en agents pathogènes | Blais-Normandin I, Tordon B, Anani W, Ning S | 2022 | Guide de la pratique transfusionnelle | View Chapitre 19. Plaquettes à teneur réduite en agents pathogènes | Health care providers | Benchmarking and standard setting |
Blood and clots series: How can I tell whether this patient has a deep vein thrombosis? | de Wit K | 2018 | CanadiEM website | View Blood and clots series: How can I tell whether this patient has a deep vein thrombosis? | Health care providers | Benchmarking and standard setting |
Current trends in clinical studies of allogeneic hematopoietic stem cell transplantation | Pilon S, Jedrysiak D, Sheppard D, Bredeson CN, Tay J, Allan DS | 2015 | Biol Blood Marrow Transplant | View Current trends in clinical studies of allogeneic hematopoietic stem cell transplantation | Health care providers | Clinical research |
Le déficit en IgA | Goldman M | 2018 | Blood.ca website | View Le déficit en IgA | Health care providers | Benchmarking and standard setting |
Recommendations for standardization of laboratory testing for drug-induced immune thrombocytopenia: communication from the SSC of the ISTH | Arnold DM, Curtis BR, Bakchoul T, for the Subcommittee on Platelet Immunology | 2015 | J Thromb Haemost | View Recommendations for standardization of laboratory testing for drug-induced immune thrombocytopenia: communication from the SSC of the ISTH | Health care providers | Benchmarking and standard setting |
The Manufacture of Platelet Products | Devine DV, Serrano K | 2013 | Platelet Transfusion Therapy | View The Manufacture of Platelet Products | Health care providers | Other |
Transfusion-related acute lung injury after transfusion of pooled immune globulin: a case report | Quest GR, Gaal H, Clarke G, Nahirniak S | 2014 | Transfusion | View Transfusion-related acute lung injury after transfusion of pooled immune globulin: a case report | Health care providers | Clinical research |
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. | Cuker A AG, Chong BH, Cines DB, Greinacher A, Gruel Y, Linkins LA, Rodner SB, Selleng S, Warkentin TE, Wex A, Mustafa RA, Morgan RL, Santesso N | 2018 | Blood Adv | View American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. | Health care providers | Benchmarking and standard setting |
The importance of iron for whole blood donors: a Canadian perspective | Pambrun C, Goldman M | 2018 | Blood.ca website | View The importance of iron for whole blood donors: a Canadian perspective | Health care providers | Other |
Système Diego : l’anticorps anti-Wra | Meunier D, Peng S, Clarke G | 2019 | Blood.ca website | View Système Diego : l’anticorps anti-Wra | Health care providers | Benchmarking and standard setting |
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Jenkins C | 2021 | Blood.ca website | Health care providers | Benchmarking and standard setting | |
Irradiated, Washed and CMV Seronegative Blood Components | Prokopchuk-Gauk O, Solh Z | 2021 | Clinical Guide to Transfusion | View Irradiated, Washed and CMV Seronegative Blood Components | Health care providers | Benchmarking and standard setting |
Platelet Disorders | Crowther M, Zawilska K, M?ynarski W, Arnold D | 2020 | McMaster Textbook of Internal Medicine | Health care providers | Benchmarking and standard setting | |
Massive Hemorrhage Protocol: Quality Metrics Portal Pilot | Thompson T, Callum J | 2022 | Ontario Regional Blood Coordinating Network February 2022 Newsletter | View Massive Hemorrhage Protocol: Quality Metrics Portal Pilot | Health care providers | Clinical research |
International Forum on the Management of Major Haemorrhage: Responses | Green L, Stanworth S, McQuilten Z, Lin V, Tucker H, Jackson B, Badawi M, Hindawi S, Chaurasia R, Patidar G, Pandey HC, Fasola F, Miyata S, Matsumoto M, Matsushita T, Rahimi-Levene N, Peer V, Pavenski K, Callum J, Thompson T, Murphy M, Staves J, Maegele M, Abeyakoon C, Rushford K, Wood E, Nuñez MA, Mellado S, Saa E, Triyono T, Pratomo B, Apelseth TO, Dunbar N | 2022 | Vox Sang | View International Forum on the Management of Major Haemorrhage: Responses | Health care providers | Benchmarking and standard setting |
From MPOX to the next epidemic: Words matter when talking about equity-deserving groups | Butler-Foster T, Khandelwal A, Montemayor C, Miller YM, Yan MTS, Holmberg JA, Ipe TS, Accooe P, Cancelas JA | 2023 | Transfusion | View From MPOX to the next epidemic: Words matter when talking about equity-deserving groups | Health care providers | Ethical, legal & social implications research |
Plasma transfusion practices: A multicentre electronic audit | Khandelwal A, Minuk L, Liu Y, Arnold DM, Heddle NM, Barty R, Hsia C, Solh Z, Shehata N, Thompson T, Tinmouth A, Perelman I, Skeate R, Kron AT, Callum J | 2022 | Vox Sang | View Plasma transfusion practices: A multicentre electronic audit | Health care providers | Clinical research |
Serologic reactivity of unidentified specificity in antenatal testing and hemolytic disease of the fetus and newborn: The BEST collaborative study | Lu W, Ziman A, Yan MTS, Waters A, Virk MS, Tran A, Tang H, Shih AW, Scally E, Raval JS, Pandey S, Pagano MB, Shan H, Moore C, Morrison D, Cormack O, Fitzgerald J, Duncan J, Corean J, Clarke G, Yazer M | 2023 | Transfusion | View Serologic reactivity of unidentified specificity in antenatal testing and hemolytic disease of the fetus and newborn: The BEST collaborative study | Health care providers | Clinical research |
Chapter 14. Therapeutic apheresis | Oliver M, Patriquin C | 2023 | Clinical Guide to Transfusion | View Chapter 14. Therapeutic apheresis | Health care providers | Benchmarking and standard setting |
Circular of information for the use of human blood components: Whole Blood | Stewart T | 2022 | Blood.ca website | View Circular of information for the use of human blood components: Whole Blood | Health care providers | Benchmarking and standard setting |
A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia | Mahabir VK, Ross C, Popovic S, Sur ML, Bourgeois J, Lim W, George JN, Wang G, Cook RJ, Toltl LJ, Nazi I, Kelton JG, Arnold DM | 2013 | Eur J Haematol | View A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia | Health care providers | Clinical research |
Composants sanguins négatifs pour les anti-CMV, irradiés et lavés | Prokopchuk-Gauk O, Solh Z | 2017 | Guide de la pratique transfusionnelle | View Composants sanguins négatifs pour les anti-CMV, irradiés et lavés | Health care providers | Benchmarking and standard setting |
Evaluating the "family veto" of consent for organ donation | Toews M, Caulfield T | 2016 | CMAJ | View Evaluating the "family veto" of consent for organ donation | Health care providers | Other |
Fatal false-negative transfusion infection involving a buffy coat platelet pool contaminated with biofilm-positive Staphylococcus epidermidis: a case report | Kou Y, Pagotto F, Hannach B, Ramirez-Arcos S | 2015 | Transfusion | View Fatal false-negative transfusion infection involving a buffy coat platelet pool contaminated with biofilm-positive Staphylococcus epidermidis: a case report | Health care providers | Clinical research |
Outcomes of both abbreviated hyper-CVAD induction followed by autologous hematopoietic cell transplantation and conventional chemotherapy for mantle cell lymphoma: a 10-year single-centre experience with literature review | Alwasaidi TA, Hamadah A, Altouri S, Tay J, McDiarmid S, Faught C, Allan D, Huebsch L, Bredeson C, Bence-Bruckler I | 2015 | Cancer Med | View Outcomes of both abbreviated hyper-CVAD induction followed by autologous hematopoietic cell transplantation and conventional chemotherapy for mantle cell lymphoma: a 10-year single-centre experience with literature review | Health care providers | Clinical research |
Prothrombin complex concentrate for emergent reversal of warfarin: an international survey of hospital protocols | Gorlin J, Kinney S, Fung M, Tinmouth A | 2017 | Vox Sang | View Prothrombin complex concentrate for emergent reversal of warfarin: an international survey of hospital protocols | Health care providers | Clinical research |